U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.

Submitted by mike kraft on

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk | CNN After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness. Katherine Dillinger CNN

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Demographics
Disease Prevention
Government
Health
Medical Testing
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -